Navigation Links
NCCS and Clearbridge Biomedics open the region's first circulating tumor cell center

16th January 2014, Singapore A collaboration between National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) has resulted in the establishment of the region's first Circulating Tumour Cell Centre of Research Excellence (CTC CoRE). This new Centre facilitates the use of circulating tumour cells (CTCs) in clinical diagnostics, in order for new technologies to be applied by healthcare institutions.

The CTC CoRE is a key enabler in Singapore's efforts to advance the development of personalised medicine, which is the customised healthcare of an individual patient. The research being undertaken at the CTC CoRE aims to understand the genetic make-up of a patient's cancer cells, which can evolve over time.

To determine the effectiveness of treatment, blood samples will be drawn from the patient pre- and post-treatment. The blood samples are sent to the Cytology Lab at SGH and put through the ClearCell FX system to separate the cancer cells from other blood components. Using a cytogenetic test, the number of cancer cells are counted and documented. If there is no significant reduction in the number of cancer cells, the oncologist may decide to modify the treatment regime to best combat the cancer. Not only does this result in a dramatic effectiveness in cancer therapy management, it also leads to reduced side effects and significant cost savings.

The CTC CoRE is located at the newly-opened Academia, within SGH's 12,000 sqm Pathology Department. This allows researchers at the CTC CoRE to have access to the cytology, immunohistochemistry, cytogenetics and molecular capabilities at the Department.

The CTC CoRE will focus on a number of research programmes and clinical trials at NCCS and SGH, with support from Clearbridge BioMedics. These include the pilot use of the ClearCell FX system, which is Clearbridge BioMedics' novel label-free enrichment system for CTCs, first invented at the National University of Singapore. The CTC CoRE will also be developing novel CTC diagnostic assays for personalised medicine that will enable clinicians to tailor therapies to individual patients' unique genetic make-up. It is envisioned that these diagnostic assays will eventually be adopted as part of routine clinical service, enabling clinicians to obtain real-time feedback on therapeutic effectiveness, in order to improve cancer management and patient outcomes.

"With the establishment of this CTC CoRE, Clearbridge BioMedics is now entering the clinical diagnostics field. We are delighted to work with the leading cancer centre in Singapore, to validate the clinical utility of our ClearCell FX system, which we target to be in the clinic by 2015. The ultimate aim is for the CTC CoRE to allow cancer clinicians to access technologies that reliably process and analyse patients' blood, for actionable clinical results," said Johnson Chen, Director, Clearbridge BioMedics Pte Ltd.

"Circulating tumour cells have the potential to become a powerful tool in how oncologists diagnose, treat and manage cancers. Setting up this CTC CoRE facility will allow our researchers to characterise these cells real-time, even as a patient's tumour evolves due to treatment and time. This will boost NCCS's position as a centre for cancer management, as well as enhance Singapore's reputation as an oncology thought leader in Asia," said Professor Soo Khee Chee, Director, National Cancer Centre Singapore.

"Pathology represents the final bridge between basic science and clinical medicine. The Pathology Department at SGH is able to serve as an incubator for biomedical care, research and innovation. By understanding the genetic make-up of a patient's cancer cells, personalising cancer treatment can be achieved. This collaboration will enable us to leverage on each other's expertise and explore new technologies to improve patient care and outcomes," said Associate Professor Tan Puay Hoon, Head, Department of Pathology, Singapore General Hospital.


Contact: Rachel Tan

Related medicine news :

1. Researchers Map Brain Regions Linked to Intelligence
2. Certain Genetic Regions May Be Tied to Osteoporosis
3. Scientists ID New Gene Regions Linked to Type 2 Diabetes
4. Regions vary in paying prisoners to participate in research
5. Imaging study examines effect of fructose on brain regions that regulate appetite
6. Brains of Fetuses Build a Bridge Between Regions, Images Show
7. Regions Hospital Reports Success with BESLER’s BVerified(SM) Suite of Revenue Recovery Solutions
8. Finds Jobs in South Atlantic and South West Central Regions Mirroring Current Employment Trends
9. Increasing construction in APAC and EMEA regions are the main drivers for its increasing consumption globally for Concrete Admixtures - New Report by MarketsandMarkets
10. Higher cancer incidences found in regions near refineries and plants that release benzene
11. Growing share of HIV/AIDS burden shifts to changing group of regions
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, ... Table 1-1 ). More than 3.7 billion people under the age of 50 – ... according to WHO's first global estimates of HSV-1 infection . , "The data shocks ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by ... of issues that are presently affecting Americans. Dedicated to providing the world with a ... the subjects consumers focus on, one episode at a time. , In the ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to announce ... (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored to ... of twelve colleges and universities in the state of California make the cut. CBD ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  The total global healthcare industry is expected to grow ... Latin America has the highest projected growth at ... Japan ), is second with growth projected at 11.5%. ... healthcare expenditure. In 2013-2014, total government funded healthcare was nearly ... to 41.2% in 2013-2014. In real terms, out of pocket ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... Nov. 25, 2015 AAIPharma Services Corp./Cambridge ... of at least $15.8  Million to expand its ... NC . The expansion will provide additional ... the growing demands of the pharmaceutical and biotechnology ... expansion will provide up to 40,000 square feet ...
Breaking Medicine Technology: